GL1X · GenesisL1 explorer

Research workbench

Y74COX mutant of plasmodium falciparum triosephosphate isomerase

Analyse Y74COX mutant of plasmodium falciparum triosephosphate isomerase in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5GZP
Type
protein
Length
492 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.03
Source
Plasmodium falciparum
Molecule
Triosephosphate isomerase
EC
5.3.1.1
UniProt
Q07412
Ligands
PGA
Pockets
6 · best druggability 0.81

Structure

x-ray diffraction · resolution 2.03 · 1 distinct chain · 44% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTriosephosphate isomerase (EC 5.3.1.1)protein24644% helix, 16% strandQ07412

Ligands and binding sites

  • PGA · 2-phosphoglycolic acid · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 11 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11730.810.9628EDO
21460.470.7722empty
3570.370.7911empty
4630.330.7618empty
5790.310.7417empty

Interfaces

1 interface between chains.

  • A–B · 1307 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 5GZP · Y74COX mutant of plasmodium falciparum triosephosphate isomerase · the same entry in another collection · chain A against A, TM-score 1.00
  • Q07412 · AlphaFold monomer V2.0 prediction for triosephosphate isomerase (Q07412) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.